ARHGEF16 and cancer: IHC results indicated that the expression of the proliferation marker Ki67 and that of MMP9, which is involved in cancer invasion and metastasis, was significantly increased in the ARHGEF16-overexpressing xenograft tumors (Fig. 3e).